Holen Sie sich die Stockscreener-App
3.55
0.84%
-0.03
Handel nachbörslich:
3.62
0.07
+1.97%
Schlusskurs vom Vortag:
$3.58
Offen:
$3.63
24-Stunden-Volumen:
306.81K
Relative Volume:
0.65
Marktkapitalisierung:
$187.40M
Einnahmen:
$17.63M
Nettoeinkommen (Verlust:
$-57.71M
KGV:
-2.3986
EPS:
-1.48
Netto-Cashflow:
$-60.45M
1W Leistung:
+1.28%
1M Leistung:
+49.79%
6M Leistung:
-1.93%
1J Leistung:
-9.44%
1-Tages-Spanne:
$3.51
$3.72
1-Wochen-Bereich:
$3.23
$3.735
52-Wochen-Spanne:
$1.94
$5.65
Scpharmaceuticals Inc Stock (SCPH) Company Profile
Firmenname
Scpharmaceuticals Inc
Sektor
Branche
Telefon
617-517-0730
Adresse
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
Vergleichen Sie SCPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCPH
Scpharmaceuticals Inc
|
3.55 | 185.04M | 17.63M | -57.71M | -60.45M | -1.48 |
|
ONC
Beone Medicines Ltd Adr
|
246.68 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.09 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.30 | 40.37M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.39 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
77.49 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-07 | Eingeleitet | Craig Hallum | Buy |
| 2022-12-01 | Eingeleitet | Cowen | Outperform |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-10-11 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-02 | Eingeleitet | Maxim Group | Buy |
| 2021-09-09 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-10-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-01-30 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
Alle ansehen
Scpharmaceuticals Inc Aktie (SCPH) Neueste Nachrichten
Northern Trust Corp Grows Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Wearable Injector Market Is Booming So Rapidly 2025-2032 - openPR.com
BNP Paribas Financial Markets Increases Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Shareholders Will Likely Find scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Acceptable - simplywall.st
Captrust Financial Advisors Acquires 21,523 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 - Seeking Alpha
Price T Rowe Associates Inc. MD Buys Shares of 15,143 scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by Comerica Bank - Defense World
Leerink Partnrs Analysts Lower Earnings Estimates for SCPH - Defense World
What is HC Wainwright’s Estimate for SCPH Q1 Earnings? - Defense World
What is Leerink Partnrs’ Forecast for SCPH FY2027 Earnings? - Defense World
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2025 Earnings Call Transcript - Insider Monkey
Market Sentiment Around Loss-Making scPharmaceuticals Inc. (NASDAQ:SCPH) - simplywall.st
scPharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
scPharmaceuticals Earnings Call Highlights Growth and Expansion - TipRanks
ScPharmaceuticals targets CKD launch and rising Medicare fill rates to accelerate FUROSCIX growth trajectory - MSN
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates - MSN
ScPharmaceuticals Doubles FUROSCIX Sales In Q1, Launches In CKD, Eyes Autoinjector Filing In Q3 - Nasdaq
scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion - Yahoo
scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: R - GuruFocus
scPharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
SCPH Reports Revenue Growth and Positive Outlook for FUROSCIX | - GuruFocus
Earnings call transcript: SC Pharmaceuticals Q1 2025 results miss forecast By Investing.com - Investing.com South Africa
Earnings call transcript: SC Pharmaceuticals Q1 2025 results miss forecast - Investing.com
scPharmaceuticals Inc Reports Q1 2025 Revenue of $11.8 Million, Exceeding Estimates; EPS Details Not Provided - GuruFocus
scPharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SCPH Reports Revenue Growth and Positive Outlook for FUROSCIX | SCPH Stock News - GuruFocus
scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Wells Fargo & Company MN Purchases 9,663 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Insights Ahead: scPharmaceuticals's Quarterly Earnings - Nasdaq
scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Kno - GuruFocus
Barclays PLC Buys 24,717 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals (SCPH) Expected to Announce Earnings on Tuesday - Defense World
89,690 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Bought by Raymond James Financial Inc. - Defense World
scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025 - The Manila Times
Invesco Ltd. Purchases 6,073 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
JPMorgan Chase & Co. Raises Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences - The Manila Times
scPharmaceuticals Expands Investor Outreach: CEO Set for Citizens, Craig-Hallum, and Wainwright Conferences - Stock Titan
Geode Capital Management LLC Boosts Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Stock Market Recap: scPharmaceuticals Inc (SCPH) Concludes at 2.63, a -5.23 Surge/Decline - DWinneX
Purple Biotech (NASDAQ:PPBT) versus scPharmaceuticals (NASDAQ:SCPH) Financial Review - Defense World
Corebridge Financial Inc. Raises Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Raymond James Financial Inc. Makes New $318,000 Investment in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Raymond James Financial Inc. Invests $318,000 in scPharmaceuticals Inc. (NASDAQ:SCPH) - The AM Reporter
SCPH stock touches 52-week low at $2.19 amid market challenges - Investing.com
U.S. FDA approves ScPharmaceuticals' heart failure therapy - MarketScreener
Market Cool On scPharmaceuticals Inc.'s (NASDAQ:SCPH) Revenues Pushing Shares 30% Lower - simplywall.st
Charles Schwab Investment Management Inc. Acquires 26,964 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Bank of New York Mellon Corp Raises Stock Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Finanzdaten der Scpharmaceuticals Inc-Aktie (SCPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):